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'E r Oral administration of Factor Vlllin lipid vesicles
H. C. Hemker and R' F. A' Zwaal
T h e p r e v e n t i o n o r t r e a t m e n t o f s e v e r e b | e e d i n g s i n p a t i e n t s w i t h
h a e m o p h i | i a A p r e s e n t l y d e p e n d s o n i n t r a v e n o u s a d m i n i s t r a t i o n o f p a r t i a | | y
p u r i f i e d p r e p a r a t i o n s o f t h e m i s s i n g c o a g u | a t i o n F a c t o r V l | l . l n s p i t e o f t h e
r e v o l u t i o n a r y b r e a k t h r o u g h t h a t c a r r r e i n t h e t r e a t m e n t o f h a e m o p h i l i a c s w i t h
the  in t roduc t ion  o f  su i tab le  Fac tor  v l l l  p repara t ions  
fo r  c l in ica l  use ,  th is
therapy st i l l  presents a variety of problems' not 
the least of them being the
r e c u r r e n t i n j e c t i o n s t h e m s e l v e s . O r a l a d m i n i s t r a t i o n o f t h e s e F a c t o r V l | |
p r e p a r a t i o n s i s u s e l e s s d u e t o e x t e n s i v e d e g r a d a t i o n o f t h e p r o t e i n i n t h e
gastrointestinal tract. This breakdown may be overcome 
to a certain extent
i f  the protein is packed in l iposomes' which may 
decrease exposure to the
digestive proteolyt ic enzymes '  l t  has been 
reported that l iposome
ent rapped pro te ins  a re  capab le  o f  en ter ing  in tac t  ce l l s "  
and insu l in  loaded
l i p o s o m e s a d m í n i s t e r e d o r a l l y t o d i a b e t i c r a t s c a n c a u s e a f a l I i n t h e b | o o d
g iucose leve l^ .
F A C T O R  V I I I  " L O A D E D  L I P O S O M E S
L i p o s o m e s a r e a r t i f i c i a l s t r u c t u r e s o f m u I t i | a m e l | a r c o n c e n t r i c
b i l a y e r s o f p h o s p h o | i p i d s t h a t f o r m s p o n t a n e o u s I y u p o n s u s p e n d i n g I i p i d s i n
*a te .3 .  when l iposomes are  prepared in  the  presence o f  
aqueous so lu t ion
of  a  p ro te in ,  5 -15 t  o f  the  pro te in  may become ent rapped 
in  the  in te rs t i ces
between the  b i layersA.  Because fac to r  V l l l  has  been repor ted  
to  in te rac t
hydrophob ica l l y  w i th  phospho l ip ids) ,  w€ thought  tha t  i t  m igh t  be  
poss ib le  to
p r e f e r e n t i a l l y a b s o r b F a c t o r V l I l o n p h o s p h o l i p i d s a n d t h e r e f o r e o b t a i n
I iposomes w i th  a  much h igher  Fac tor  V l l  I  con ten t  than 
is  usua l ly  ob ta ined
w i t h n o n - l i p i d b i n d i n g p r o t e i n s . l n s p i t e o f t h e f a c t t h a t I i p o s o m e s a n d
t h e i r e n t r a p p e d p r o t e i n s a r e a l s o s u s c e p t i b l e t o g a s t r o i n t e s t i n a l b r e a k d o w n '
i r e t h o u g h t t h a t t h e s p e c i f i c b i n d i n g o f F a c t o r V | | l t o t h e l i p i d s a n d t h e
nuch h igher  p ro te in  load ing  o f  the  l iposome'  wou ld  p roduce 
an  inc reased
res ls tance to  p ro teo ly t i c  a t tack  and improve the  chances  
fo r  the  pro te in  to
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reach the target undamaged.





a n t i b o d i e s J .  '
i n t ravenous adr l
in  l iposomes)  a
o f  the  l iposomei
and re tu rned 3
when e i ther  l Íp
F a c t o r  V l l I  a d n
V l l l  a c t i v i t y .
in t ravenous adr '
tha t  o ra l l y  admi
is l iberated fronr
Repeat
resu l ts ,  bu t  va
1 ) .  O f  t h e  6
showed a  s ign i f i r
per iod  requ i redr
increase was ot
p a t i e n t s .  l t  i s
inc rease in  seru
thêt the Factor
wh ich  may l im i t  t
D  I S C U S S I O  N
A I  thoug
The prepara t ions  to  be  used fo r  o ra l  admin is t ra t ion  were  made
f rom egg yo lk  lec i th in  conta in ing  5-1  0?  o f  phosphat id ic  ac id  and so lu t ions  o f
e i ther  Fac tor "  V l  l  l  concent ra te  o r  c ryoprec ip i ta te .  Usua l ly  50  mg o f
phospho l ip id  were  used per  ml  o f  Fac tor  v l l l  so lu t ion .  A  de ta i led
descr ip t ion  o f  the  procedure  has  been pub l ishedo.
The fract ion of non-entrapped protein can be measured in the
supernatan t  a f te r  cen t r i fug ing  the  l iposomes a t  50 ,000 x  g  fo r  l0  minu tes .
Th is  f lu id  conta ined l9 -329 o f  the  or ig ina l  Fac tor  V l l  I  added and usua l ly
m o r e ' t h a n  8 0 8  o f  t h e  f i b r i n o g e n  p r e s e n t  i n  F a c t o r  V l l l  p r e p a r a t i o n s .  T h i s
s t rong ly  suggests  tha t  the  l iposome prepara t ions  are  indeed pre feren t ia l l y
enr iched w i th  Fac tor  V l l l ,  p resumably  due to  the  s t rong in te rac t ion  be tween
Factor  v l l l  and  the  l ip ids .  D i rec t  measurement  o f  the  en t rapped pro te in
has  so  fa r  been hampered by  the  presence o f  phospho l ip ids .  l t  i s  no t  to
be expec ted ,  however ,  tha t  s ign i f i can t  denatura t ion  o f  Fac tor  V l l l  occuns
because car ry ing  ou t  the  same man ipu la t ions  w i th  a  Fac tor  V l l l  so lu t ion  ln
the  absence o f  l ip ids  causes  less  than 58  inac t iva t ion .
t r i n ' r r o  1 F a c t o r  V l l l  a c t i v i t y  i n  p l a s m a  a f t e r  o r a l  a n d  i n t r a v e n o u s
a d m i n i s t r a t i o n  o f  F a c t o r  V l l l  t o  a  p a t i e n t  w i t h  s e v e r e
haemoph i l ia .  Concent ra t ions  were  de termined accord inq  to
- t -
V e l t k a m p '  a n d  a r e  e x p r e s s e d  a s  a  p e r c e n t a g e  o f  F a c t o r  V l l l
c o n c e n t r a t i o n  i n  p o o l e d  n o r m a l  p l a s m a  ( n  =  3 0 )
ntravenous
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Each sample was tested 4 t imes. SEM did not exceed 9t of
va lue  observed.  A t  zero  t ime 800 un i ts  o f  Fac tor  V l l I  were
g iven ora l l y  o r  in t ravenous ly .  Fac tor  V l l l  concent ra t ion  in
the  un t rea ted  sub jec t  i s  less  than 0 '58  o f  normal '
concent ra t ion  a f te r  in t ravenous admin is t ra t ion  measured
before t hours were between 30? and 15t and have been
omitted from the graPh.
O R A L  A D M I N I S T R A T I O N
l n a f i r s t e x p e r i m e n t F a c t o r V | | | | o a d e d l i p o s o m e s w e r e g i v e n
b e f o r e b r e a k f a s t t o a p a t i e n t w i t h s e v e r e h a e m o p h i | i a A { m e a n F a c t o r V l t l
leve l  when no t  on  t rea tment  less  than 0 .5 t  o f  normal ;  no  c i rcu la t ing
ant ibod ies) .  The resu l ts  a re  shown in  F igure  
' l  
'  P lasma leve ls  a f te r
in t ravenous admin is t ra t ion  o f  the  same amount  o f  Fac tor  v l l l  
(no t  ên t rapped
in  l iposomes)  a re  a lso  shown.  The pa t ien t  had haematur ia  be fore  inges t ion
o f t h e | i p o s o m e p r e p a r a t i o n ; t h i s d i s a p p e a r e d o n t h e d a y o f t h e e x p e r i m e n t
and re tu rned 3  days  therea f te r .  P lasma Fac tor  V l l l  ac t i v i t y  d id  no t  r i se
when e i ther  l iposomes or  Fac tor  V l l l  were  g iven separa te ly .  some o f  the
Factor  v l l  I  admin is te red  in  the  l iposornes  appeared in  the  p lasma as  Fac tor
v l l l  ac t i v i t y .  Th is  ac t i v i t y ,  though much lower  than observed shor t l y  a f te r
in t ravenous admin is t ra t ion ,  pers is ted  fo r  some 50 hours"  Th is  suggests
tha t  o ra l l y  admin is te red  Fac tor  V l l l  does  no t  en ter  the  p lasma d i rec t l y  bu t
is  l ibera ted  f rom an as  ye t  unknown depot '
R e p e a t i n g t h e e x p e r i m e n ! w i t h t h e s a m e p a t i e n t p r o d u c e d s i m i l a r
resu l ts ,  bu t  var iab le  resu l ts  were  ob ta ined w i th  d i f fe ren t  pa t ien ts  (Tab le
1 ) . o f t h e 6 p a t i e n t s ( a l l w i t h o u t c i r c u l a t i n g a n t i b o d i e s ) , 2 p a t i e n t s
showed a  s ign i f i can t  and prophy lac t ic  inc rease o f  some 108 a l though the  t ime
per iod  requ i red  to  reach th is  leve l  var ied  '  ln  2  pa t ien ts  on ly  a  minor
i n c r e a s e w a s o b s e r v e d w h e r e a s t r e a t m e n t w a s i n e f f e c t i v e w i t h 2 o t h e r
p a t i e n t s . l t i S t o b e n o t e d t h a t i n n o i n s t a n c e c o u l d a n y s i g n i f i c a n t
i n c r e a s e i n s e r u m p h o s p h o I i p i d c o n c e n t r a t i o n b e d e t e c t e d . T h i s s u g g e s t s
tha t  the  Fac tor  V l l l  con ta in ing  l iposomes do  no t  en ter  the  b lood as  such,
wh ich  may l im i t  the  chances  fo r  new ant ibod ies  to  fo rm'
D I S C U S S I O N













comparable to, or even longer than. that observed after intravênous
admin is t ra t ion  o f  the  sa Íne  amount  o f  Fac tor  V l l l .  l {e  have no  exp lanat ion
for the fact that some patients show l i t t le or no response. The effïcacy of
the treatment wil l  certainry depend upon protection from, and t ime of
exposure  to ,  p ro teo ly t i c  d iges t ion  in  the  gas t ro in tes t ina l  t rac t .  In  th is
respec t  i t  i s  o f  in te res t  tha t  upon ora l  admin is t ra t ion  o f  ínsu l in  loaded
liposomes to fasted and non-fasted rats, we only observed a large drop in
b lood g lucose leve l  in  the  group o f  fas ted  ra ts  (F igure  2) .  A  d i f fe rence in
resorption t ime may be responsible for this effect. whether or not the
res is tance to  d iges t ive  enzymes can a lso  be  improved by  ar te r ing  the
phosphot ip id  compos i t ion  s t i l l  needs  to  be  inves t iqa ted .
Tab le  1 orat  adminis t rat ion of  1300 u Factor  Vl l l  concentrate,  t rapped
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1 0 . 0  ( x  =  1 . 5  h )
1 0 . 2  ( x = 4  h )
1 . 4  { x = 2  h )
1 . 2  ( x = 2  h )
no change in 5 h
no changê in 5 h
Figure 2
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Pat ients 4-6 d id not  receive the mater iar  on an êmpty stomach.
we conclude that  ora l  adminis t rat ion of  Factor  Vl l l  Ín  l iposomes
can lead to therapeut ic  p lasma levels of  Factor  v l l l ,  a l though the
circumstances required for a successful treatment are not yet completely
understood.  A more extensive invest igat ion is  requi red in  which par t icuíar
at tent ion should be paid to possib le undesi red ant igenic react ions,  a l though
at  present  we have no indicat ions that  these occur .
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F igu re  2 Plasma levels of glucose after oral administration of l iposome
entrapped insul in  to fasted and non-fasted rats.  -n- t r - ,
non- fasted rats;  -O*O- ,  fasted rats;  -A-A -  '  non-
en t rapped  i nsu l i n ;  -O -O- ,  i n t rape r i t onea l  adm in i s t ra t i on
of  non-entrapped insul in
A C  K N O W L E D G E M E N T
We thank Dr.  J .W. ten Cate,  Wi lhelmina Gasthuis,  Amsterdam, for
h is  co-operat ion in  s tudying a number of  h is  pat ients.
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Dr .  Austen:
F*c to r  V l l l  i n  a i
r!!ay get 60 per









a to ta l  fa i lu re  on  a l l  counts .
Pro f .  Zwaa l :  Had we s tud ied  pa t ien t  No '  6  
f i rs t '  we
have dropped the  who le  th ing '  l t  was  ius t  a  mat te r  
o f  luck








l d o n o t k n o w w h a t D r . A u s t e n ' s p h o s p h o | i p i d c o m p o s i t i o n i s . | t
i s a b s o | u t e | y n e c e s s a r y t o h a v e a n e g a t i v e s u r f a c e c h a r g e . N o r m a l | y w e u s e
A c - l e c i t h i n c o n t a Í n i n g a b o u t l 0 p e r c e n t p h o s p h o t e r i c a c i d , o r i n b e t w e e n 5
and. l0 per  cent ,  and the negat ive sur face charge is  requi red for  Factor
V | l I t o b i n d t o t h e p h o s p h o l i p d . l t d o e s n o t s p o n t a n e o u s | y b i n d t o p u r e
l ec i th in .  The o ther  ques t ion how do we measure the entraPment?
T h e r e a r e t w o w a y s . T h e r e i s t h e v e r y e a s y w a y o f s p i n n i n g d o w n
| i p o s o m e s a n d m e a s u r i n g h o w m u c h i s | e f t i n t h e s u p e r n a t a n t . T h a t i s a
very  eàsy  way o f  do ing  i t .  The more  compl ica ted  way is  when one wants  
to
k n o w h o w m u c h i s r e a | | y e n t r a p p e d . l n o t h e r w o r d s , w h a t i s n o t m e a s u r e d
i n t h e s u p e r n a t a n t , i s t h a t r e a l | y e n t r a p p e d , o r i s t h a t d e n a t u r e d . I n i t i a l
exper iments  in  wh ich  we have degraded the  l iposomes,  w i th  phospho l ipases '
s h o w i n d e e d t h a t t h e t o t a I p r o c e d u r e t o p r e p a r e t h e l i p o s o m e s d o e s n o t
resu l t  in  a  loss  tha i  i s  more  than 5  per  cent  o f  the  Fac tor  V l l l  ac t i v i t y '  
so
w h e r e | i D o s o m e s a r e d e g r a d e d w i t h p h o s p h o | i p a s e s , F a c t o r V l l l c a n b e
measured because i t  i s  aga in  re leased and the  amount  tha t  was  en t rapped
can be  measured.



















F a c t o r  V l  I  I  i n  a n  a s s a Y  '
assay  ge t  60  Per  cent  o f
then lyse  these l iposomes,  and in  the
the  s ta r t ing  mater ia l . 3
f r o t -  L w a a t i
Pro f .  S tewar t :
p repa ra t ion  is
P r o f .  Z w a a l :
i h e  F a c t c : -  V l l  I
P r o f .  S t e v , a r t :
f , - ^ a
-::::_ ri=:l:
_;:l;s'--7-re--rdtqpw-
T h a t  i s  c o r r e c t .
Does i t  make any  d i f fe rence what  sor t  o f  Fac tor  V l l l
used ?
We have t r ied  two prepara t ions ,  the  c ryoprec ip i ta te  and
c o n c e n t r a t e .
!Vhat  concent ra te?
I t h i n k  i t  w a s  S w i s s  i n  o r i g i n b u t  I  a m  n o t  q u i t e  s u r e .
': - r'i.,g ";.:;
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Prof. Stewart: Does it make any difference?
Prof .  Zwaal :  No.  Not
patients, who always respond
Dr.  Ludlams Has prof .
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Prof .  Zwaa l : Of course we have.  The resul t  is  n i l  .
Dr' Tuddenham: what sort of recovery does prof. Zwaar get? How qxx
Factor Vrr does he put into the vesser in which he prepared the rípoem*
and how much gets into the patient?
P r o f .  Z w a a l : Assuming a trap of between 60 and g0 per cent ih6r 
":
we introduce I300 units of Factor Vil l. These are reaily entrapped u,ratr.
so we started with approximately ' l  700 or 1800 units of Factor Vll l of rttf,cfr i l
about  1300 uni ts  were entrapped,  But  the f i rs t  exper iment  was doírc  * tÈ : :
800 u n i ts .  ' : :
Dr .  Tuddenham: How much got  in to the pat ient?
Prof .  Zwaa l :  We have no t  rea l l y  measured
leve l  above 5  per  cent  i s  ma in ta ined fo r  a t  leas t
than the  leve l  reached w i th  an  in t ravenous in jec t ion .
Dr .  Peope r : As Prof. Zwaal states, specif ic entrapment is uru*i l
rather ineff icient, and 60 per cent does imply some kind of specif ic afrrf t , i t ï .
I s  there  any  o ther  ev idence,  apar t  f rom those numbers ,  o f  the  na tu . "  d
the  in te rac t ion  wh ich  you pos tu la ted  be tween V l l l c  and the  phospho l ip ; * *  r *
t h i s  s i t u a t i o n ?
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Prof . Zwaat:  Normal ly given pure label led Factor Vl l l ,  one can do
b ind ing  cons tan ts  be tween Fac tor  V l l l  and  phospho l ip ids .  As  I  s ta ted ,  th is
depends on  the  negat ive  sur face  charge wh ich  is  very  s imi la r  to  Fac tor  V .
Dr.  Pepper: ls it reported by anybody else in this sort of situation?
Prof .  Zwaa l  :  That  there  is  a  b ind ing  o f  Fac tor  V l l l  in  the  l ip ids?
think there are a number of indications from the l i terature, but as far as
can recal l  there is no separate art icle devoted to that.
Prof .  B loom: Dr.  Pepper is  ask ing whether  prof .  Hemker has
repeated h is  ear l ier  exper iments wi th the use of  phosphol ip ids that  they are
actual ly  us ing in  the l iposomes,
Prof .  Zwaa l :  No,  he  has  no t .  Bu t  I  showed ver .y  ear ly  exper iments .
But ,  when we take  the  pure  Fac tor  V l l l  p repara t ions  as  are  present ly  be ing
prepared,  we can labe l  them and measure  b ind ing  be tween these Fac tor  v l l l
and  the  l ip ids ,  and we f ind  on ly  h igh  a f f in i t y  when the  l ip id  i s  negat ive ly
charqed.
D r .  B i r c h : H ow sta ble a re
practical terms if they are not l ikely to
refrigerator for some time, they may not
l i posomal  p repara t ions  because in
prove stable on the bench or in the
be o f  much use.
Pro f .  Zd ,aa l : Normal ly  a l iposome preparat ion is  s table when i t  is  not
s ter i l i sed  fo r  about  2  to  3  days  in  a  re f r igera tor .  l t  m igh t  be  in te res t ing
to  look  a t  whether  one can lyophy l l i se  the  comple te  l iposomal  p repara t ion ,
or  jus t  f reeze i t  and see whether  i t  can  be  used aga in  w i thout  any .  loss  o f
ac t iv i t y  in  the  Fac tor  V l l  l .  Bu t  th is  has  no t  been done.  Normal ly  the
prepara t ion  is  s tab le  fo r  about  2  to  3  days .
Dr .  De lamore : Has anyone t r ied  g iv ing  i t  w i th  the  appropr ia te
to  see whether  tha t  w i l l  p romotê  absorp t ion?l ipo ly t ic  enzymes
130
P r o f .  Z w a a l :
Dr .  De lamore :
L-".n
e n z y m e s .
Pro f .  Zwaa l :  The fác t  tha t  i t
exper iments ,  fo r  about  3  days  a t
s imp ly  suggests  tha t  i t  i s  l ibera ted
'{+r....l{.s,e..aËl|sie
Why should one promote absorpt ion?
Prof .  Zwaa l  d id  suggest  tha t  i f  i t  was  no t  g iven  on  a
he did not get the appropriate action from l ipolyt ic
Prof .  Zwaal :  The idea behind i t  is  very s imple,  that  there is  an
enhanced degradation due to the production of l ipolytic enzyÍnes when the
stomach is not empty. But one can simply degrade the l iposomes by
l ipoly t ic  enzymes.  Of  course one can.  And then the Factor  Vl l l  is
l iberated.
Prof .  B loom:  Then presumably  i t  wou ld  no t  ge t  absorbed.  Can Pro f .
Zwaa l  pos tu la te  the  mechan isms o f  absorp t ion?
P r o f .  Z w a a l : I  have no idea.  I  can speculate on i t .  l t  has been
shown tha t  normal ly  most  o f  the  lec i th in  wh ich  is  admin is te red  ora l l y  i s
degraded,  and the  fa t ty  ac ids  o f  the  lec i th in  appear  fo r  ins tance in
t r ig lycer ides  in  the  b lood.  l t  has  a lso  been shown tha t  under  ce i ta in
cond i t ions  lec i th in  can be  taken up  comple te ly  as  a  comple te  rno lecu le .  But
in  th is  case we have measured the  poss ib i l i t y  o f  a  r i se  in  the  serum leve ls
o f .  lec i th in  in  the  p lasma and we cou ld  no t  de tec t  any ,  whereas  we cou ld
have when most  o f  the  lec i th in  wou ld  have been l ibera ted  to  the  p lasma.
Prof ,  F loom: Presumably th is  goes in to the por ta l  syste: i ,  in to the
chyle.  Does i t  get  a deposi t  there in  the lymph nodes?
i s  ma in ta ined,  a t  leas t  in  the  success fu l
a  leve l  o f  be tween 5  and I0  per  cent
f rom a  depot  as  ve t  unknown.
Pro f .  B loom: Which  is  why  I  asked whether  the  depot  cou id  poss ib ly
be in  the  lymphat ic  sys tem.
F1>."1141: !i" "w.
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Prof .  Zwaa l :
Dr .  Pres ton :
patients with vl
Pro f .  Zwaa l :
do  th is ,  bu t  
€
labora tory .  We
Prof. Bloom:





Has there been an opportunity to test the liposomes in
patients with vW disease?
Prof. Zwaal: That is a very good questíon. We are really wil l ing to
do this, but as I mentioned this is only a very small sideline ih our
laboratory. We do not normalty do research into haemophil ia.
Prof., Bloonl: This is a very exciting possibil i ty. I really hope that
i t  does develop.
It could be. lt could be anywhere.
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